オプションチェーンは、BioVieの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、BioVieの市場センチメントを評価します。.

BioVie (NASDAQ:BIVI) 株価情報, オプションチェーン

BioVie

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

BioVie Inc

BIVICTRIX THERAPEUTICS PL by BIVICTRIX THERAPEUTICS PLC

BiVictriX Therapeutics PLC

News

NTRA

Reported Earlier, Natera To Present Latest Data On Signatera At 2024 San Antonio Breast Cancer Symposium

Elon Musk&#8216;s company, Neuralink, is set to initiate a new feasibility trial involving its innovative brain implant technology and a robotic arm. This trial aims to explore the safety and effectiveness of Neuralink&#8217;s wireless brain-computer interface and surgical robot.
What Happened: The study, named PRIME, will focus on patients with quadriplegia, enabling them to control external devices through thought, Reuters reported on Tuesday. Neuralink plans to enroll participants from its ongoing PRIME trial into this feasibility study, as mentioned in a post on social media platform X.
Recently, Neuralink received <a href="https://www.benzinga.com/24/11/42103314/elon-musks-neuralink-gets-green-light-to-launch-brain-chip-trial-in-canada-recruitment-is-now-open">approval from Health Canada</a> to conduct a trial of its device in Canada. Canadian neurosurgeons, in collaboration with Neuralink, have been authorized to recruit six patients with paralysis for the study. In the U.S., Neuralink has already implanted the device in two patients, allowing one to engage in activities such as playing video games and browsing the internet.
See Also: <a href="https://www.benzinga.com/news/24/11/42157649/trumps-doge-co-lead-elon-musk-slams-lockheed-martins-f-35-fighter-jets-advocates-drone-warfare-as-pentagon-defends-1-8-trillion-program?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump&#8217;s DOGE Co-Lead Elon Musk Slams Lockheed Martin&#8217;s F-35 Fighter Jets, Advocates Drone Warfare As Pentagon Defends $1.8 Trillion Program</a>
The company reports that the device is functioning well in the second patient, who is&nbsp;using it to play video&nbsp;games and learn 3D design. The U.S. FDA and Neuralink have not yet provided further&nbsp;details on the feasibility study.
Why It Matters: The potential of Neuralink&#8217;s brain chip technology to transform lives has been a topic of interest since Musk first introduced the concept. As reported in July, Musk <a href="https://www.benzinga.com/startups/24/07/40016299/we-want-to-give-people-super-powers-elon-musk-envisions-neuralink-brain-chip-transforming-lives-like">envisioned the brain chip </a>offering superhuman abilities, akin to characters from science fiction like Geordi La Forge from Star Trek. The company, founded in 2016, aims to revolutionize the way humans interact with technology and address neurological disorders through brain-computer interfaces (BCIs). 
The initial human trials began earlier this year with Noland Arbaugh, a 30-year-old quadriplegic, who received the N1 Implant, allowing him to control a computer cursor with his thoughts.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/42152721/tesla-cybertruck-part-of-donald-trumps-motorcade-will-vehicle-land-government-deals?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Cybertruck Part Of Donald Trump&#8217;s Motorcade, Will Vehicle Land Government Deals?</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

General

Elon Musk's Neuralink To Launch New Feasibility Trial With Brain Implant And Robotic Arm

With U.S. stock futures trading slightly higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) to report quarterly earnings at $1.29 per share on revenue of $9.63 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Best Buy shares rose 0.4% to $93.37 in after-hours trading.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTX#NASDAQ">PSTX</a>) agreed to be acquired by Roche in a $1.5 billion deal. Poseida Therapeutics shares jumped 11.2% to $3.18 in the after-hours trading session.</li>
<li>Analysts expect HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) to post quarterly earnings at 93 cents per share on revenue of $13.99 billion. The company will release earnings after the markets close. HP shares fell 0.3% to $39.19 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Zoom Video Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) posted better-than-expected results for its third quarter and raised its guidance for the full year. Zoom reported third-quarter revenue of $1.18 billion, beating the consensus estimate of $1.16 billion. The communications company reported third-quarter adjusted earnings of $1.38 per share, beating analyst estimates of $1.31 per share. Zoom shares fell 5.6% to $84.09 in the after-hours trading session.</li>
<li>Analysts expect Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) to report quarterly earnings at $2.05 per share on revenue of $24.65 billion after the closing bell. Dell shares fell 0.8% to $143.00 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>
Photo courtesy: Flickr

Earnings

Pre-Market Outlook

Markets

Trading Ideas

DELL

PSTX

Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday

<ul>
<li>The annual dividend on the common stock of the Corporation was raised to $1.16 per share from $1.13 per share.</li>
<li>The Board of Directors authorized the first quarterly dividend of 29.00 cents ($0.2900) a share to be paid on February 18, 2025, to stockholders of record at the close of business on January 13, 2025.</li>
</ul>

Dividends

Reported Earlier, Hormel Foods Increases Annual Dividend By 3% To $1.16/Share; Declared First Quarterly Dividend Of $0.29/Share Payable February 18, 2025

CHARU

Reported Earlier, Charlton Aria Acquisition Announces Separate Trading Of Class A Shares And Rights Starting November 26

Berry plans to use proceeds from the transaction to pay down outstanding debt at Berry. Adjusted for both the cash distribution received in November 2024 on close of Berry's Health, Hygiene and Specialties Global Nonwovens and Films business ("HHNF") spin-off, and the net cash proceeds1 expected on the sale of Tapes, totaling $1.3 billion, Berry's pro forma net debt as of September 30, 2024 was approximately $5.9 billion (3.5x LTM net leverage).

BERY

Reported Earlier, Berry Global Sells Specialty Tapes Business To Nautic Partners For $540M

Justin Sun, the founder of the TRON (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/trx/usd">TRX</a>) blockchain, announced a $30 million investment in President-elect Donald Trump-backed cryptocurrency project&nbsp;World Liberty Financial&nbsp;(WLFI), lending support to the &#8220;Make America Great Again&#8221; movement.
What Happened: On Monday, Sun revealed on X that Tron became the largest investor in&nbsp;the decentralized finance (DeFi) project with the strategic expenditure. 
He said, &#8220;The U.S. is becoming the blockchain hub, and Bitcoin owes it to Donald Trump!  TRON is committed to making America great again and leading innovation. Let&#8217;s go!&#8221;
In response, the WLFI team said they were honored to have the support of Sun and the Tron ecosystem.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We are thrilled to invest $30 million in World Liberty Financial <a href="https://twitter.com/worldlibertyfi?ref_src=twsrc%5Etfw">@worldlibertyfi</a> as its largest investor. The U.S. is becoming the blockchain hub, and Bitcoin owes it to <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a>! TRON is committed to making America great again and leading innovation. Let&#39;s go! <a href="https://t.co/cISTsVYP1f">pic.twitter.com/cISTsVYP1f</a>
&mdash; H.E. Justin Sun &#x1f34c; (@justinsuntron) <a href="https://twitter.com/justinsuntron/status/1861121947372773545?ref_src=twsrc%5Etfw">November 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Sun&#8217;s $30 million investment catapulted total sales of the project&#8217;s governance token past $50 million, <a href="https://dune.com/fergmolina/world-liberty-financial" target="_blank" rel="noreferrer noopener">according&nbsp;</a>to a Dune Analytics dashboard, although still a long way away from the ambitious $300 million target.
The project had a slow start, managing to raise just 4% of its token presale target within the first 48 hours of its launch.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42180180/peter-schiff-warns-trumps-bitcoin-support-could-lead-to-economic-chaos-make-america-weaker-as-wall-street-misallocates-bigly">Peter Schiff Warns Trump&#8217;s Bitcoin Support Could Lead To Economic Chaos, Make America &#8216;Weaker&#8217; As Wall Street Misallocates &#8216;Bigly&#8217;</a>
Why It Matters: Promoted aggressively by Trump and his family,&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40905315/donald-trumps-new-crypto-project-world-liberty-financial-everything-you-need-to-know" target="_blank" rel="noreferrer noopener">the project</a>&nbsp;attracted significant attention right in the middle of the GOP nominee&#8217;s presidential campaign.
The WLFI token would serve as the platform&#8217;s governance token, enabling users to engage in borrowing, lending, and other DeFi activities. However, its non-transferable, non-yielding nature may have turned off speculative traders, adding to the lackluster presale.
According to the World Liberty Gold&nbsp;Paper, WLFI <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41395007/trump-affiliated-entity-will-get-75-of-world-liberty-financials-revenue-and-22-of-wlfi-tok">would allocate 75% of its protocol revenues</a> to a firm associated with the former President, DT Marks DEFI, LLC.
As for Sun, he remains one of the largest publicly known cryptocurrency investors, boasting a portfolio worth more than $1.8 billion, <a href="https://platform.arkhamintelligence.com/explorer/entity/justin-sun" target="_blank" rel="noreferrer noopener">data </a>from Arkham Intelligence revealed.
Photo Courtesy: Wikimedia Commons
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42179537/rumble-bets-on-bitcoin-with-new-treasury-strategy-ceo-calls-it-an-excellent-addition">Rumble Bets On Bitcoin With New Treasury Strategy, CEO Calls It An &#8216;Excellent Addition&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$TRX

Crypto Billionaire Justin Sun Pledges $30M Investment In Trump-Backed World Liberty Financial: What's Happening?

Sell-side clients benefit from simplified integration and connectivity to LTX, reduced operational risk and implementation costs and improved time-to-marke

Broadridge's LTX Partners With TransFICC, Offering  Faster Access And Lower Costs For Fixed Income eTrading

The Company expects to receive aggregate gross proceeds of US$8.20 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters an option, exercisable within forty-five (45) days after the closing of the Offering, to purchase up to an additional 307,500 ADSs at the public offering price, less underwriting discounts. The Offering is expected to close on or about November 27, 2024, subject to the satisfaction of customary closing conditions.

IPOs

WYHG

Reported Earlier, Wing Yip Food Prices Its $8.2M Initial Public Offering Of 2.05M American Depositary Shares At $4/ADS

Guidance
In the Group's Annual Report 2023, Cadeler provided guidance for the financial year ending 31 December 2024 indicating that full-year revenue was expected to fall within the range of EUR 225 million to EUR 245 million, while full-year EBITDA was expected to be between EUR 105 million and EUR 125 million. Cadeler has today increased its revenue guidance for the financial year 2024, as it now expects full-year revenue to fall within the range of EUR 243 million to EUR 253 million, principally due to clients calling more options under the Group's existing contracts than was previously assumed, higher vessel utilisation as a result of the Group having secured contracts for the provision of operations and maintenance services between installation projects, and the receipt of termination fees in respect of a vessel reservation agreement. In addition, Cadeler has revised and narrowed its EBITDA guidance within the upper end of the range it has previously communicated, as it now expects full-year EBITDA to range between EUR 115 million and 125 million.

Guidance

CDLR

Cadeler Expects FY24 Revenue Of €243M-€253M (Prior €225M-€245M)

If finalized, the loan would support the construction of Rivian's next facility in Stanton Springs North, near the city of Social Circle, Georgia, substantially expanding the company's domestic production capacity to support demand from the United States and international markets. This loan from DOE would provide significant funding for production of the company's midsize platform, which underpins the R2, a midsize SUV, and the R3/R3X, a midsize crossover. Designed, engineered, and built in America to deliver an incredible combination of capability, function, performance, and pricing, Rivian believes its R2 and R3 vehicle lines will be critical drivers in the company's long-term growth and profitability.

RIVN

Reported Earlier, Rivian Secures Conditional $6.6B DOE Loan Commitment To Expand Electric Vehicle Manufacturing And Development In US

Cadeler Reported Q3 Revenue Of €81M Vs €23M YoY

Financial analyst Jim Cramer&#8216;s recent recommendation to &#8220;own&#8221; Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) stocks has triggered a widespread investor revolt, with social media users loudly proclaiming their intent to do the opposite.
What Happened: CNBC&#8217;s &#8220;Mad Money&#8221; host Cramer&#8217;s Monday statement on X, &#8220;Apple, own it, don&#8217;t trade it!&#8221; quickly became a catalyst for what traders call the &#8216;Inverse Cramer&#8217; phenomenon—a strategy where investors systematically bet against his stock recommendations.
Online commentary ranged from satirical to scathing. One user, Tommy Famous, criticized Cramer as a &#8220;financial QVC&#8221; who has &#8220;led audiences into losses,&#8221; suggesting his recommendations are more entertainment than serious financial advice.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Jim Cramer, you've officially cemented yourself as the ultimate inverse indicator. Every word you utter is like a green light for the opposite trade. ‘Apple, own it, don't trade it'? Nah, that translates to SELL IT IMMEDIATELY and SHORT IT TO THE GROUND. You're not a market…
&mdash; Tommy Famous (@TommyBeFamous) <a href="https://twitter.com/TommyBeFamous/status/1861055066964123941?ref_src=twsrc%5Etfw">November 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/global/24/11/42179729/as-nvidia-maintains-chip-supremacy-jim-cramer-says-the-so-called-enemies-of-semiconductor-giant-arent-really-enemies">As Nvidia Maintains Chip Supremacy, Jim Cramer Says Foes Of Semiconductor Giant &#8216;Aren&#8217;t Really Enemies&#8217;</a>
Notable social media reactions included Thomas Peters <a href="https://x.com/thomasopeters/status/1861106660028358992">describing</a> it as &#8220;a great run&#8221; but ultimately follows the Inverse Cramer strategy. Another user <a href="https://x.com/Kyl0Z3n/status/1861062070470332662">humorously</a> suggested it&#8217;s time to sell Apple shares. Some users even pledged to <a href="https://x.com/thecryptomars/status/1861055235235422225">switch</a> technology brands in response. 
The phenomenon isn&#8217;t new. In October 2022, Tuttle Capital launched ETFs specifically designed to track and potentially profit from Cramer&#8217;s stock picks—including an &#8220;Inverse Cramer&#8221; fund that recently announced its shutdown.
Matthew Tuttle, CEO of Tuttle Capital, stated the ETF&#8217;s original mission was to &#8220;point out the danger of following TV stock pickers&#8221; and demonstrate the <a href="https://www.benzinga.com/etfs/specialty-etfs/24/01/36793492/exclusive-inverse-cramer-etf-shuts-down-how-the-magnificent-7-stocks-factor-in-and-a-broken-c">lack of consistent accountability</a> in financial media recommendations.
It is interesting to note that Cramer also predicted Vice President Kamala Harris's victory over now President-elect Donald Trump in the 2024 election on Nov. 4, <a href="https://www.cnbc.com/2024/11/04/cramer-says-mondays-action-suggests-some-anticipate-a-harris-win.html">according</a> to CNBC. "I'm not sure the market's right about what a Harris presidency would mean for business, but at least now we have a blueprint for what Wall Street thinks it'll mean," he said.
Price Action: Apple&#8217;s stock closed Monday at $232.87, up 1.31% for the day, with a year-to-date gain of 25.44%, according to <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42180029/ark-invest-shakes-up-portfolio-with-big-tesla-and-amazon-trades">Cathie Wood-Led Ark Invest&#8217;s Latest Portfolio Maneuver: Dumps Tesla And Palantir Shares, Buys Amazon And AMD Stock</a></li>
</ul>
Image via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Equities

AAPL

Jim Cramer's Apple Endorsement Sparks 'Inverse Cramer' Backlash As Social Media Users Mock His 'Own It' Advice

Reported Earlier, Replimune Prices $140M Upsized Public Offering Of&nbsp;6,923,000 Common Shares At $13/Share

REPL

Reported Earlier, Replimune Prices $140M Upsized Public Offering Of 6,923,000 Common Shares At $13/Share

SKYSCRAPER-01 is a global Phase III, randomized, double-blinded study evaluating tiragolumab plus Tecentriq compared to Tecentriq alone in 534 patients with PD-L1-high previously untreated, locally advanced unresectable or metastatic NSCLC. Patients were randomized 1:1 to receive either tiragolumab plus Tecentriq or placebo plus Tecentriq, until disease progression, loss of clinical benefit, or unacceptable toxicity. The study did not reach the primary endpoint of overall survival at the final analysis. The overall safety profile observed remained consistent with longer follow-up, and no new safety signals were identified. The detailed data will be presented at a medical meeting in 2025.

RHHBF

RHHBY

RHHVF

Roche's Genentech Provides Update On SKYSCRAPER-01 Phase III Study In PD-L1-High NSCLC Patients

Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash; transaction represents total equity value of up to $1.5 billion
Poseida to join the Roche Group and advance its innovative pipeline of non-viral, TSCM-rich CAR-T therapies and genetic medicines as part of Roche's Pharmaceuticals

Poseida Therapeutics To Be Acquired bB Roche In $1.5B Deal, Stockholders To Receive Up To $13/ Share In Cash

NASA has selected Elon Musk&#8216;s SpaceX to provide launch services for a rotorcraft lander mission aimed at exploring the largest moon of the planet Saturn in July 2028
What Happened: The deal is priced at about $256.6 million, including launch services and other related costs. 
The mission is expected to fly in the period from July 5 to July 25, 2028, on a SpaceX Falcon Heavy rocket from Florida to explore the moon called Titan. 
&#8220;Dragonfly centers on novel approach to planetary exploration, employing a rotorcraft-lander to travel between and sample diverse sites on Saturn's largest moon,&#8221; NASA said in a statement.
The mission is aimed at identifying the habitability of Titan's environment and searching for chemical indications of whether water-based or hydrocarbon-based life once existed on Saturn's moon, among other goals.
Why It Matters: SpaceX has multiple contracts with NASA to fly astronauts and cargo to the International Space Station (ISS) and also to <a href="https://www.benzinga.com/news/24/07/39870115/spacex-ceo-elon-musk-says-safe-destruction-of-international-space-station-will-be-a-very-dramatic-ev">bring down the space station</a> upon its retirement around 2030. 
NASA is also relying on a particular version of SpaceX&#8217;s Starship launch vehicle called the <a href="https://www.benzinga.com/24/11/42108681/spacex-shows-off-conceptual-version-of-starship-which-will-help-humans-land-back-on-moon-in-over-50-yrs">Human Landing System or HLS</a> to enable astronauts to land back on the surface of the Moon for the first time since 1972.
During the Artemis 3 mission, slated for no earlier than September 2026, the Starship HLS will be launched first and it will wait for NASA's Orion spacecraft in lunar orbit after filling its tanks in space. Once the Orion spacecraft arrives, the HLS will dock with it. Two of the four crew members on the mission will transfer from Orion to Starship and descend to the surface of the moon.
The last time humans set foot on the Moon was in 1972 <a href="https://www.benzinga.com/news/24/01/36692749/just-a-worse-version-of-apollo-elon-musk-baffled-by-nasa-veterans-push-to-ditch-spacex-blue-origin-a" target="_blank" rel="noreferrer noopener">with Apollo 17</a>. Since then, no crew has traveled beyond low-Earth orbit.
While SpaceX is not yet listed on the exchanges, investors can leverage Destiny Tech100 Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXYZ#NYSE">DXYZ</a>) and Cathie Wood&#8216;s Ark Venture Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKVX#NASDAQ">ARKVX</a>) to participate in the Musk-led space company's growth.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42058338/byd-makes-a-million-nevs-in-less-than-2-months" target="_blank" rel="noreferrer noopener">BYD Makes A Million NEVs In Less Than 2 Months After Beating Tesla For The First Time Since 2022 In Quarterly Revenue</a></li>
</ul>
Photo courtesy: NASA

SPACE

ARKVX

DXYZ

SpaceX Falcon Heavy To Launch NASA's Dragonfly Mission To Saturn's Largest Moon In 2028

The Company intends to use the net proceeds of this offering, together with cash on hand, including from recent sales under the Company's "at the market" offering program, to repay the $478.0 million mortgage loan with a fixed effective interest rate of approximately 9.0% and which is secured by its Washington Square property. Pending such use, the Compa

Macerich Prices Upsized $395M Public Offering Of 20M Common Shares At $19.75/Share

Nokia and du conclude successful transport network slicing trial in UAE
<ul>
<li>Nokia network slicing technology will help du tailor segments customized to user needs.</li>
<li>The first of its kind in the region, the live transport network slicing deployment will cater to specific requirements for bandwidth, latency, and reliability.</li>
</ul>

Nokia And du Complete Successful Trial Of Transport Network Slicing In The UAE

Telegram has reported significant financial growth in the first half of 2024, with revenue reaching $525 million, driven by strong performance in cryptocurrency holdings. This is despite ongoing legal challenges facing its CEO, Pavel Durov.
What Happened: Telegram&#8217;s financial disclosures indicate that the company has benefited from the rising value of its cryptocurrency holdings, which have grown to $1.3 billion, <a href="https://www.ft.com/content/a48acdae-6a6c-4073-894f-89ef5cf8b185">reported</a> Financial Times, citing the company's unaudited financial statements.
This increase, along with proceeds from selling Toncoins, has provided a financial cushion for the Dubai-based firm amid Durov&#8217;s legal troubles.
In August, Durov was detained by <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40558693/telegram-ceo-pavel-durov-faces-12-serious-charges-french-prosecutor-reveals">French authorities in Paris</a>, facing preliminary charges related to alleged criminal activities on the platform.&nbsp;
See Also: <a href="https://www.benzinga.com/24/11/42154224/weekend-round-up-ai-dominates-headlines-with-nvidia-elon-musk-and-hollywoods-big-names?itm_source=parsely-api">Weekend Round-Up: AI Dominates Headlines With Nvidia, Elon Musk, And Hollywood&#8217;s Big Names</a>
Despite these challenges, Telegram informed investors that the situation has not materially impacted its operations.
The company generated $225 million from a one-time deal involving Toncoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TON</a>), initially developed by Telegram but now managed by an open-source community. 
Telegram&#8217;s financial statements also show a post-tax profit of $335 million for the first half of the year.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: Telegram&#8217;s financial health has been under scrutiny, especially with reports suggesting a <a href="https://www.benzinga.com/news/24/09/40669018/telegrams-financial-health-in-question-a-roadblock-to-30b-ipo">loss of $108 million on revenue</a> of $342 million in the previous year.
Despite these challenges, the company has been eyeing a $30 billion IPO in 2026. It remains focused on monetization through ads and premium subscriptions.
A significant portion of Telegram&#8217;s revenue, over 40%, is derived from <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40659490/telegram-derives-40-of-its-revenue-from-crypto-related-operations">crypto-related operations</a>, including its integrated wallet and sale of collectibles.
This reliance on cryptocurrency has provided a financial buffer amid legal challenges.
Additionally, <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41437710/v3v-ventures-invests-5-million-in-premium-telegram-usernames-seizing-unique-advantages-to-">investments like the $5 million</a> by V3V Ventures in premium Telegram usernames highlight the platform&#8217;s potential in the crypto space, as these usernames are seen as valuable assets for building crypto channels.
Price Action: Toncoin is priced at $6.26, reflecting a 2.16% rise over the past 24 hours. However, its trading volume has declined by 15.18%, amounting to $626.53 million at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42155932/apple-black-friday-2024-get-up-to-200-in-gift-cards-on-iphones-macs-airpods-and-more-heres-everything-you-need-to-know?itm_source=parsely-api">Apple&#8217;s 2024 Black Friday Deals: Gift Cards Over Discounts — Here&#8217;s What You&#8217;ll Get</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Social Media

Media

$TON

Telegram's $1.3B Crypto Windfall Shields Business Amid Pavel Durov's Legal Troubles, Toncoin Emerges As The Golden Goose

BioVie ( ($BIVI) ) just unveiled an update. BioVie Inc. announced a direct stock offering and a private placement, aiming to raise approximately $6...

BioVie Announces Stock Offering and Private Placement

An announcement from BioVie ( ($BIVI) ) is now available. BioVie Inc. has announced the successful closing of a registered direct offering and conc...

BioVie Secures $6.66 Million Through Direct Offering

BioVie (BIVI) announced the pricing of a registered direct offering of 2.667M shares of its common stock priced at-the-market under Nasdaq rules at...

BioVie 2.667M share registered direct offering priced at $2.25

An update from BioVie ( ($BIVI) ) is now available. BioVie Inc., a clinical-stage company, has announced a registered direct offering and concurren...

BioVie Announces $6 Million Stock Offering and Placement

BioVie ( ($BIVI) ) has provided an update. BioVie Inc., a clinical-stage company developing treatments for chronic conditions, has successfully clo...

BioVie Raises $6 Million in Strategic Funding

BioVie (BIVI) announced the pricing of a registered direct offering of 1,146,000 shares of its common stock priced at-the-market under Nasdaq rules...

BioVie 1.15M share registered direct offering priced at $2.83

Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGS – VF Corp. (VFC) up 21.5% F5 Networks (FFIV...

Closing Bell Movers: VF Corp. surges after quarterly results

An announcement from BioVie ( ($BIVI) ) is now available. BioVie Inc. announced the successful closing of its registered direct offering, raising $...

BioVie Raises $3.24 Million in Direct Offering

BioVie (BIVI) announced that the upcoming PD-202 A Double-Blind, Randomized, Placebo-controlled, Study of Bezisterim in Subjects with Early Parkins...

BioVie says Parkinson's Disease clinical trial is fully funded

BioVie files to sell 7.71M shares of common stock for holders

BIVI

CDNS

FFIV

TREX

Financing

Press Releases

BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement

Join BioVie's Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024

BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Health Care

UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BioVie Inc. Announces Closing of Registered Direct Offering

BioVie's Upcoming Parkinson's Disease Clinical Trial is Fully Funded

BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference

Comments

BioVie

BioVie (BIVI) オプション

BioVie (NASDAQ:BIVI) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル